National High-tech Enterprise Awarded for 17 consecutive years Top 20 Chinese Pharmaceutical R&D Companies Awarded for 8 consecutive years 80+ Clinical approval & Production approval & New Drug Certificates 15+ International Registration (USDMF, CEP, etc. )Submitted Accumulated more than 130 items of factory technology transfer to customer enterprises
National High-tech Enterprise Awarded for 16 consecutive years Top 20 Chinese Pharmaceutical R&D Companies Awarded for 7 consecutive years 70+ clinical approval & Production approval & New Drug Certificates 10+ International Registration (USDMF, CEP, etc. )Submitted
20+ New Invention Patents Applied 2API products activated in CDE 5 finished formulation products approved for production license Shanghai Branch was established. Strengthen business expansion and layout
• Obtain the first CEP certificate • Obtain CNAS certificate • Submit MAH registration application for the first time and obtain B certificate • Two API varieties have been approved by CDE and transferred to A
• Jinghai Industrial Park R&D Center Operated • Strategic Partnership with Zezheng Pharmaceutical Established
• Subsidiary HMYA Established, International Business Operated Independently • EU & FDA Application Submitted • Top 20 Chinese Pharmaceutical R&D Companies Awarded (Reelected) • CSAIII Pilot • T100 New Technology & New Product Innovation Action Outstanding Enterprise Awarded